OUR STORY
We’re a diverse and talented group of entrepreneurs and formulation scientists with a groundbreaking set of ideas that we hope will contribute towards a better tomorrow. We provide smart solutions for overcoming biological barrier to effective drug delivery.
At Via Therapeutics , we believe treating no disease is too small and affordability and access to medications is as important as developing them.
THE VIA THERAPEUTICS TEAM
Get to Know Us
Our passion for creating meaningful change for clients is what sets us apart. The Via Therapeutics team believes in the potential of our great idea, and it truly shows in all of our work. We work tirelessly in order to bring you a better tomorrow, and we’re proud of every single member of staff. To learn more about the incredible Via Therapeutics team, please have a look below.
John Koleng, Ph.D., R.Ph.
President/CSO & Co-Founder
Dr. Koleng has over 20 years of experience in the development of Pharmaceuticals for a large array of indications and companies.
%20(1)_edited.jpg)
Zachary Warnken PharmD, Ph.D.
Director, Pharmaceutical Development
Dr. Warnken brings extensive experience in leading the development of multiple preclinical-stage drug product candidates for a variety of indications.
Hugh D.C. Smyth
Co-Founder & Chief Technology Officer
The inventions of Dr. Smyth in his capacity as faculty at The University of Texas at Austin have served as a significant portion of the foundation at Via Therapeutics. Initiating many of the developments focused on treatment of impactful diseases in an efficient and affordable manner.
